Abstract
We report a case of complete resection of lung cancer involving the thoracic aorta, after induction chemoradiotherapy in a 55-year-old man. The chemoradiotherapy, which consisted of two courses of platinum-based chemotherapy with concurrent radiation to a total of 40 Gy, resulted in a partial response. Left upper lobectomy with combined resection and reconstruction of the distal arch aorta and left subclavian artery was performed under cardiopulmonary bypass. The patient was given two courses of platinum-based adjuvant chemotherapy, and there has been no sign of recurrence in the 34 months since his operation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rice TW, Blackstone EH. Radical resections for T4 lung cancer. Surg Clin North Am. 2002;124:113–22.
Tsuchiya R, Asamura H, Kondo H, Goya T, Naruke T. Extended resection of the left atrium, great vessels, or both for lung cancer. Ann Thorac Surg. 1994;57:960–5.
Ohta M, Hirabayashi H, Shiono H, Minami M, Maeda H, Takano H, et al. Surgical resection for lung cancer with infiltration of the thoracic aorta. J Thorac Cardiovasc Surg. 2005;129:804–8.
Cerfolio RJ, Bryant AS, Jones VL, Cerfolio RM. Pulmonary resection after concurrent chemotherapy and high dose (60 Gy) radiation for non-small cell lung cancer is safe and may provide increased survival. Eur J Cardiothorac Surg. 2009;35:718–23.
Farray D, Mirkovic N, Albain KS. Multimodality therapy for stage III non-small cell lung cancer. J Clin Oncol. 2005;23:3257–69.
Misthos P, Papagiannakis G, Kokotsakis J, Lazopoulos G, Skouteli E, Lioulias A. Surgical management of lung cancer invading the aorta or the superior vena cava. Lung Cancer. 2007;56:223–7.
Klepetko W. Reply. Ann Thorac Surg. 2000;69:971–2. (letter).
Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Inter-group Trial 0160). J Clin Oncol. 2007;25:313–8.
Mayumi H, Zhang QW, Nakashima A, Masuda M, Kohno H, Kawachi Y, et al. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg. 1997;63:129–37.
Akbas H, Erdal AC, Demiralp E, Alp M. Effects of coronary artery bypass grafting on cellular immunity with or without cardiopulmonary bypass. Cardiovasc Surg. 2002;10:586–9.
Suzuki S, Usui A, Yoshida K, Matsuura A, Ichihara T, Ueda Y. Effect of cardiopulmonary bypass on cancer prognosis. Asian Cardiovasc Thorac Ann. 2010;18:536–40.
Voets AJ, Joesoef KS, van Teeffelen ME. The influence of open heart surgery on survival of patients with co-existent surgically amenable lung cancer (stage I and II). Eur J Cardiovasc Surg. 1997;12:898–902.
Pottgen C, Levegrun S, Theegarten D, Marnitz S, Grehl S, Pink R, et al. Value of 18F-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography on non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res. 2006;12:97–106.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanaka, T., Ueda, K., Hayashi, M. et al. Left upper lobectomy with combined resection of the distal arch aorta after chemoradiotherapy for locally advanced lung cancer. Gen Thorac Cardiovasc Surg 60, 363–366 (2012). https://doi.org/10.1007/s11748-012-0005-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-012-0005-7